Estimating the within-subject (CVI ) and between-subject (CVG ) biological variation of serum tryptase
- PMID: 34904391
- PMCID: PMC8959422
- DOI: 10.1002/iid3.578
Estimating the within-subject (CVI ) and between-subject (CVG ) biological variation of serum tryptase
Abstract
Background: Tryptase is used as a biomarker to support the diagnosis of anaphylaxis and hematologic diseases. In the event of a mast cell activation during anaphylaxis, a temporary increase in the concentration of tryptase may be seen. On the basis of clinical studies, an increase of 2 µg/L + 20% from basis level has been proposed as significant. To evaluate the increase in tryptase levels, the within-subject (CVI ) and between-subject (CVG ) biological variations should be known. This study was conducted to estimate the biological variation of tryptase and to identify the reference change value (RCV).
Methods: Blood samples were collected from healthy volunteers once a week consecutively over a 10-week period. Tryptase was measured by the use of a fluoroenzyme immunoassay (ImmunoCAPTM ; Thermo Fisher Scientific), and linear mixed-effects models were used to calculate the biological variation and RCV for both nontransformed and log-transformed tryptase.
Results: Fourteen presumably healthy young adults (six males and eight females, age 23-35 years) were included. The CVI was 5.6% and the CVG was 31.5% (nontransformed data). Log-transformed data showed similar results. The analytical variation (CVA ) was 6.3% and the RCV was 23.5%.
Conclusions: Young healthy adults without ongoing allergic reactions show low within-subject biological variation. Higher biological variation was observed between subjects.
Keywords: biological variation; reference change value; tryptase.
© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol. 1990;86(4 pt 2):594‐598. - PubMed
-
- Lyons J, Schwartz L, eds. Clinical Approach to a Patient With Elevated Serum Tryptase: Implications of Acute Versus Basally Elevated Levels. Springer; 2020.
-
- Passia E, Jandus P. Using baseline and peak serum tryptase levels to diagnose anaphylaxis: a review. Clin Rev Allergy Immunol. 2020;58(3):366‐376. - PubMed
-
- Baretto RL, Beck S, Heslegrave J, et al. Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective. Allergy. 2017;72(12):2031‐2034. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
